Central extracorporeal membrane oxygenation with left-ventricular vent for fulminant myocarditis: a retrospective study.
Artificial lung
ECMO
Fulminant myocarditis
Left-ventricular vent
Journal
Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs
ISSN: 1619-0904
Titre abrégé: J Artif Organs
Pays: Japan
ID NLM: 9815648
Informations de publication
Date de publication:
Dec 2023
Dec 2023
Historique:
received:
01
06
2022
accepted:
02
10
2022
medline:
13
11
2023
pubmed:
9
11
2022
entrez:
8
11
2022
Statut:
ppublish
Résumé
Fulminant myocarditis presents as acute severe heart failure and requires mechanical cardiocirculatory support. Left-ventricular (LV) decompression is necessary for the successful recovery of these patients. This retrospective study aimed to evaluate the functional outcomes of providing central extracorporeal membrane oxygenation (ECMO) with LV decompression for the treatment of refractory fulminant myocarditis. Between January 2015 and February 2021, seven consecutive fulminant myocarditis patients (mean age: 41.1 ± 26.1 years) received central ECMO support with transapical LV decompression, with an 18 French cannula integrated into the ECMO circuit in a Y-fashion. The baseline characteristics and postoperative outcomes of the patients were collected. On admission, all patients received prior peripheral ECMO, and 85.7% (6/7) of patients received prior intra-aortic balloon pumping. However, all patients had refractory cardiogenic shock that failed prior to decompression. Six patients recovered successfully after a mean ECMO support of 20.0 ± 11.5 days and five patients had no recurrence of cardiac decompensation. The mean ICU and mean hospital stays were 36.7 ± 23.5 days and 60.6 ± 24.9 days, respectively. Hospital mortality was 28.6% (2/7). Two patients died due to sepsis and stroke during hospitalization. Central ECMO with an LV vent was effective for fulminant myocarditis refractory to percutaneous cardiopulmonary support therapy and other therapies.
Identifiants
pubmed: 36348184
doi: 10.1007/s10047-022-01371-y
pii: 10.1007/s10047-022-01371-y
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
297-302Informations de copyright
© 2022. The Japanese Society for Artificial Organs.
Références
Lucas SK, Schaff HV, Flaherty JT, Gott VL, Gardner TJ. The harmful effects of ventricular distention during postischemic reperfusion. Ann Thorac Surg. 1981;32:486–94.
doi: 10.1016/S0003-4975(10)61782-1
pubmed: 6796012
Schwarz B, Mair P, Margreiter J, et al. Experience with percutaneous venoarterial cardiopulmonary bypass for emergency circulatory support. Crit Care Med. 2003;31:758–64.
doi: 10.1097/01.CCM.0000053522.55711.E3
pubmed: 12626980
Lorusso R, Centofanti P, Gelsomino S, et al. Venoarterial extracorporeal membrane oxygenation for acute fulminant myocarditis in adult patients: a 5-year multi-institutional experience. Ann Thorac Surg. 2016;101:919–26.
doi: 10.1016/j.athoracsur.2015.08.014
pubmed: 26518372
Reymond P, Bendjelid K, Giraud R, et al. To balloon or not to balloon? The effects of an intra-aortic balloon-pump on coronary artery flow during extracorporeal circulation simulating normal and low cardiac output syndromes. J Clin Med. 2021;10:5333.
doi: 10.3390/jcm10225333
pubmed: 34830619
pmcid: 8624867
Hasde Aİ, Sarıcaoğlu MC, Dikmen Yaman N, et al. Comparison of left ventricular unloading strategies on venoarterial extracorporeal life support. Interact Cardiovasc Thorac Surg. 2020. https://doi.org/10.1093/icvts/ivaa284 .
doi: 10.1093/icvts/ivaa284
pmcid: 8906780
Tschöpe C, Van Linthout S, Klein O, et al. Mechanical unloading by fulminant myocarditis: LV-IMPELLA, ECMELLA, BI-PELLA, and PROPELLA concepts. J Cardiovasc Transl Res. 2019;12:116–23.
doi: 10.1007/s12265-018-9820-2
pubmed: 30084076
Dixon SR, Henriques JPS, Mauri L, et al. A prospective feasibility trial investigating the use of the impella 2.5 system in patients undergoing high-risk percutaneous coronary intervention (The PROTECT I Trial) initial U.S. experience. JACC Cardiovasc Interv. 2009;2:91–6.
doi: 10.1016/j.jcin.2008.11.005
pubmed: 19463408
Seeker-Walker JS, Edmonds JF, Spratt EH, Conn AW. The source of coronary perfusion during partial bypass for extracorporeal membrane oxygenation (ECMO). Ann Thorac Surg. 1976;21:138–43.
doi: 10.1016/S0003-4975(10)64277-4
Cheng R, Hachamovitch R, Kittleson M, et al. Clinical outcomes in fulminant myocarditis requiring extracorporeal membrane oxygenation: a weighted meta-analysis of 170 patients. J Card Fail. 2014;20:400–6.
doi: 10.1016/j.cardfail.2014.03.005
pubmed: 24642377